Clinical trials
Phase 2 Disruptive, Impulse Control, and Conduct Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 4 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Chicago | 5 |
| Ohio State University | 4 |
| University of Minnesota | 2 |
| Hospices Civils de Lyon | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Promentis Pharmaceuticals, Inc. | 1 |
| University Hospital, Clermont-Ferrand | 1 |
| University Hospital, Strasbourg, France | 1 |
| University of Wisconsin, Milwaukee | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disruptive, Impulse Control, and Conduct Disorders | 17 |
| Parkinson Disease | 3 |
| Trichotillomania | 2 |
| Alcoholism | 1 |
| Compulsive Sexual Behavior Disorder | 1 |
| Excoriation Disorder | 1 |
| Inflammation | 1 |
| Obsessive-Compulsive Disorder | 1 |
Trials
Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.